Gurjeet Kaur

2.5k total citations
135 papers, 1.8k citations indexed

About

Gurjeet Kaur is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Gurjeet Kaur has authored 135 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 21 papers in Epidemiology and 20 papers in Oncology. Recurrent topics in Gurjeet Kaur's work include Molecular Biology Techniques and Applications (7 papers), Cancer-related Molecular Pathways (6 papers) and Glycosylation and Glycoproteins Research (6 papers). Gurjeet Kaur is often cited by papers focused on Molecular Biology Techniques and Applications (7 papers), Cancer-related Molecular Pathways (6 papers) and Glycosylation and Glycoproteins Research (6 papers). Gurjeet Kaur collaborates with scholars based in Malaysia, India and Australia. Gurjeet Kaur's co-authors include Chern Ein Oon, Venugopal Balakrishnan, Peter Hoffmann, Martin K. Oehler, Vikneswaran Murugaiyah, Matthew T. Briggs, Nicolle H. Packer, Arun Everest‐Dass, Frans H.J. Maurer and Balakrishnan Kunasundari and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Bioresource Technology.

In The Last Decade

Gurjeet Kaur

118 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gurjeet Kaur Malaysia 24 696 205 193 190 185 135 1.8k
Lirong Chen China 25 451 0.6× 156 0.8× 164 0.8× 133 0.7× 299 1.6× 106 1.9k
Fang Zhou China 29 1.1k 1.6× 150 0.7× 269 1.4× 211 1.1× 444 2.4× 94 2.1k
Zhiqiang Huang China 30 764 1.1× 230 1.1× 140 0.7× 119 0.6× 344 1.9× 140 2.4k
Fei Liao China 28 1.3k 1.9× 140 0.7× 240 1.2× 173 0.9× 235 1.3× 211 2.7k
Yongbo Peng China 32 1.4k 2.0× 96 0.5× 196 1.0× 477 2.5× 228 1.2× 111 2.6k
Lihua Zhang China 24 923 1.3× 380 1.9× 242 1.3× 84 0.4× 208 1.1× 128 2.2k
Shun Zhang China 30 990 1.4× 392 1.9× 317 1.6× 157 0.8× 209 1.1× 152 2.8k
Huafang Wang China 24 716 1.0× 119 0.6× 145 0.8× 365 1.9× 435 2.4× 130 2.3k
Yingying Zhao China 27 870 1.3× 166 0.8× 319 1.7× 143 0.8× 114 0.6× 145 2.0k

Countries citing papers authored by Gurjeet Kaur

Since Specialization
Citations

This map shows the geographic impact of Gurjeet Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gurjeet Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gurjeet Kaur more than expected).

Fields of papers citing papers by Gurjeet Kaur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gurjeet Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gurjeet Kaur. The network helps show where Gurjeet Kaur may publish in the future.

Co-authorship network of co-authors of Gurjeet Kaur

This figure shows the co-authorship network connecting the top 25 collaborators of Gurjeet Kaur. A scholar is included among the top collaborators of Gurjeet Kaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gurjeet Kaur. Gurjeet Kaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaur, Gurjeet, et al.. (2025). Mirrored Metastatic Neuroendocrine Tumor in a Mother-Daughter Duo With Mutations in the MEN1 Gene. Clinical Nuclear Medicine. 50(5). e307–e309.
2.
Prajapat, Manisha, Phulen Sarma, Gurjeet Kaur, et al.. (2025). Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/β-catenin pathway modulation for amyloid-β-induced Alzheimer's disease model. Journal of Alzheimer s Disease. 107(2). 857–878.
3.
Gan, Chee‐Yuen, Gurjeet Kaur, Pike-See Cheah, et al.. (2025). Acute and Subacute Oral Toxicity Assessment of The Polysaccharides Extracted from <i>Clinacanthus nutans</i> Leaves: A Preclinical Model for Drug Safety Screening. Tropical Life Sciences Research. 36(1). 245–276.
4.
Sharma, Gajanand, Anil Thakur, Jaspreet Singh, et al.. (2024). Investigating in-depth potential of lipid-engineered emulsomes of aceclofenac for the management of arthritis: A comprehensive preclinical study. Inorganic Chemistry Communications. 172. 113737–113737.
5.
Mydin, Rabiatul Basria S. M. N., et al.. (2024). Salivaomics in head and neck cancer. Clinica Chimica Acta. 565. 119952–119952. 1 indexed citations
8.
Kaur, Gurjeet, Saloni Sharma, Neha Bhardwaj, Manoj K. Nayak, & Akash Deep. (2024). Highly sensitive and selective electrochemical detection of Aflatoxin B1 in water and Pistachio samples with MOF/MXene composite based sensor. Food Control. 165. 110694–110694. 22 indexed citations
9.
Alshehade, Salah Abdalrazak, Michael L. Mathai, Nelli Giribabu, et al.. (2023). Orthosiphon aristatus (Blume) Miq Alleviates Non-Alcoholic Fatty Liver Disease via Antioxidant Activities in C57BL/6 Obese Mice and Palmitic–Oleic Acid-Induced Steatosis in HepG2 Cells. Pharmaceuticals. 16(1). 109–109. 5 indexed citations
10.
Prajapat, Manisha, et al.. (2023). Integrated in-silico and in-vitro assessments of HDAC6 inhibitor efficacy in mitigating amyloid beta pathology in Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics. 42(18). 9720–9730. 4 indexed citations
11.
Kaur, Gurjeet, Manisha Prajapat, Phulen Sarma, et al.. (2023). Investigating the novel-binding site of RPA2 on Menin and predicting the effect of point mutation of Menin through protein–protein interactions. Scientific Reports. 13(1). 9337–9337. 1 indexed citations
12.
Ismail, Zhari, et al.. (2020). Toxicological, Antidiarrhoeal and Antispasmodic Activities of Syzygium myrtifolium. Revista Brasileira de Farmacognosia. 30(3). 397–405. 3 indexed citations
13.
Kaur, Gurjeet, et al.. (2019). Andrographolide is neither a human organic anion transporter 1 (hOAT1) substrate nor inhibitor. Journal of Asian Natural Products Research. 21(8). 754–771. 1 indexed citations
14.
Kaur, Gurjeet, et al.. (2019). The inhibitory effects of mitragynine on P-glycoprotein in vitro. Naunyn-Schmiedeberg s Archives of Pharmacology. 392(4). 481–496. 22 indexed citations
15.
Asif, Muhammad, Gurjeet Kaur, Loiy Elsir Ahmed Hassan, et al.. (2018). Toxicological studies of Orthosiphon stamineus (Misai Kucing) standardized ethanol extract in combination with gemcitabine in athymic nude mice model. Journal of Advanced Research. 15. 59–68. 23 indexed citations
16.
Tan, Ming, et al.. (2012). Lack of Increased P15INK4BProtein Expression in Basal Cell Carcinomas. Asian Pacific Journal of Cancer Prevention. 13(12). 6239–6244. 2 indexed citations
17.
Kaur, Gurjeet, et al.. (2011). Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.. PubMed. 134. 186–92. 28 indexed citations
18.
Kaur, Gurjeet, et al.. (2008). Myxoid liposarcoma of the breast in a 25‐year‐old female as a diagnostic pitfall in fine needle aspiration cytology: Report of a rare case. Diagnostic Cytopathology. 36(9). 674–677. 16 indexed citations
19.
Kaur, Gurjeet, et al.. (2006). Comparison of Effectiveness of Computerized and Conventional Fixed and Learning Module in Undergraduate Pathology Teaching. 9. 213–218. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026